Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 25, 2015 6:39 PM ET

Biotechnology

Company Overview of T2 Biosystems, Inc.

Company Overview

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States. Its T2 Magnetic Resonance platform enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company offers T2Dx, a bench-top instrument for sepsis, Lyme disease, and other applications; T2Candida panel for identifying pathogens associated with sepsis; and T2MR Platform, a magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. It is also developing T2Stat, an integrated instrument that provi...

101 Hartwell Avenue

Lexington, MA 02421

United States

Founded in 2006

110 Employees

Phone:

718-491-3400

Fax:

781-357-3080

Key Executives for T2 Biosystems, Inc.

Chief Executive Officer, President and Director
Age: 54
Total Annual Compensation: $350.0K
Chief Financial Officer and Chief Accounting Officer
Age: 38
Total Annual Compensation: $171.9K
Chief Operating Officer
Age: 55
Total Annual Compensation: $89.8K
Compensation as of Fiscal Year 2013.

T2 Biosystems, Inc. Key Developments

T2 Biosystems, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-03-2015 10:00 AM

T2 Biosystems, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-03-2015 10:00 AM. Venue: The Boston Marriott Copley Place, Boston, Massachusetts, United States. Speakers: John P. McDonough, Chief Executive Officer, President and Director.

T2 Biosystems, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

T2 Biosystems, Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company reported loss from operations of $8,838,000 against $5,639,000 a year ago. Net loss was $9,076,000 against $6,374,000 a year ago. Net loss applicable to common stockholders was $9,076,000 or $0.45 per basic and diluted share against $8,284 million or $5.89 per diluted share a year ago. For the year, the company reported loss from operations of $30,681,000 against $19,692,000 a year ago. Net loss was $31,390,000 against $20,610,000 a year ago. Net loss applicable to common stockholders was $35,960,000 or $4.15 per diluted share against $27,518,000 or $19.72 per diluted share a year ago.

T2 Biosystems, Inc. to Report Q4, 2014 Results on Feb 17, 2015

T2 Biosystems, Inc. announced that they will report Q4, 2014 results at 5:00 PM, Eastern Standard Time on Feb 17, 2015

Similar Private Companies By Industry

Company Name Region
Inception 4, Inc. United States
NEONC Technologies, Inc. United States
SurModics Pharmaceuticals, Inc. United States
Lifeblood Biological Services, LLC United States
Rosetta Genomics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact T2 Biosystems, Inc., please visit www.t2biosystems.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.